By Nigam Arora & Dr. Natasha Arora
KB Home stock (KBH) is long from $16.15. It is trading at $81.96 as of this writing, representing a 407% gain.
Trump Enthusiasm
There is enthusiasm in home builder KBH stock. KBH is seeing extremely aggressive buying on expectations of another Trump presidency and potential interest rate cuts. The expectation is that Trump will hammer the Fed to cut rates quickly if he is re-elected.
Breakout
Following technical analysis, KBH stock has broken out.
Earnings
KHB reported above consensus earnings in Q2.
Note the following:
- Demand is healthy.
- Mortgage rate volatility is not tempering demand.
- Cycle times are improving.
Buyout Target
KBH is a buyout target. To date, 195 Arora portfolio companies have been bought out, producing a fortune for members who constantly invest in buyout targets.
Zones
For those who are following the Good Way, the Buy Now rating is NO.
For those following the Best Way, the buy zone is $61.31 – $68.68.
The recommended quantity is 20% of full core position size.
The very long term target is being raised to $111 – $118.
What To Do Now
Those in the stock may consider continuing to hold.
Those not in the stock may consider following the parameters given above.
Note: Signal(s) to enter, add, reduce, exit, hold or change.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
